TrialSchizophrenia research2023

Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia.

Toral S Surti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.